Orient EuroPharma Balance Sheet Health
Financial Health criteria checks 2/6
Orient EuroPharma has a total shareholder equity of NT$4.2B and total debt of NT$4.4B, which brings its debt-to-equity ratio to 105.4%. Its total assets and total liabilities are NT$10.8B and NT$6.6B respectively. Orient EuroPharma's EBIT is NT$70.6M making its interest coverage ratio 1.3. It has cash and short-term investments of NT$2.1B.
Key information
105.4%
Debt to equity ratio
NT$4.39b
Debt
| Interest coverage ratio | 1.3x |
| Cash | NT$2.10b |
| Equity | NT$4.16b |
| Total liabilities | NT$6.65b |
| Total assets | NT$10.81b |
Recent financial health updates
Here's Why Orient EuroPharma (GTSM:4120) Has A Meaningful Debt Burden
Apr 04
We Think Orient EuroPharma (GTSM:4120) Can Stay On Top Of Its Debt
Jan 04
Recent updates
Here's Why Orient EuroPharma (GTSM:4120) Has A Meaningful Debt Burden
Apr 04Is Orient EuroPharma Co., Ltd.'s (GTSM:4120) 3.3% Dividend Worth Your Time?
Mar 04A Look At Orient EuroPharma's (GTSM:4120) Share Price Returns
Feb 10Is Orient EuroPharma Co., Ltd.'s (GTSM:4120) Recent Performancer Underpinned By Weak Financials?
Jan 22We Think Orient EuroPharma (GTSM:4120) Can Stay On Top Of Its Debt
Jan 04A Look At The Fair Value Of Orient EuroPharma Co., Ltd. (GTSM:4120)
Dec 17Are Dividend Investors Getting More Than They Bargained For With Orient EuroPharma Co., Ltd.'s (GTSM:4120) Dividend?
Nov 29Financial Position Analysis
Short Term Liabilities: 4120's short term assets (NT$4.2B) exceed its short term liabilities (NT$3.7B).
Long Term Liabilities: 4120's short term assets (NT$4.2B) exceed its long term liabilities (NT$2.9B).
Debt to Equity History and Analysis
Debt Level: 4120's net debt to equity ratio (54.9%) is considered high.
Reducing Debt: 4120's debt to equity ratio has increased from 34.5% to 105.4% over the past 5 years.
Debt Coverage: 4120's debt is not well covered by operating cash flow (2.8%).
Interest Coverage: 4120's interest payments on its debt are not well covered by EBIT (1.3x coverage).